<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07290117520079</udiDi>
    <basicUdiDi>729011752MPH00001CN</basicUdiDi>
    <tradeName>Tixel Periorbital Handpiece</tradeName>
    <deviceName>Tixel Periorbital Handpiece</deviceName>
    <manufacturerName>Novoxel Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000008897</manufacturerSrn>
    <authorisedRepresentativeName>mdi Europa GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000006218</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12040203</emdnCode>
    <emdnDescription>DERMAL REGENERATION EQUIPMENT</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MPH00001</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-03T00:33:23.542Z</lastUpdated>
  </row>
  <row>
    <udiDi>07290117520062</udiDi>
    <basicUdiDi>729011752MSH00001E9</basicUdiDi>
    <tradeName>Tixel Handpiece</tradeName>
    <deviceName>Tixel Handpiece</deviceName>
    <manufacturerName>Novoxel Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000008897</manufacturerSrn>
    <authorisedRepresentativeName>mdi Europa GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000006218</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12040218</emdnCode>
    <emdnDescription>ENDERMOLOGY TREATMENTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MSH00001</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-03T00:33:22.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>07290117520055</udiDi>
    <basicUdiDi>729011752MSTX0002YL</basicUdiDi>
    <tradeName>Tixel C</tradeName>
    <deviceName>Tixel C</deviceName>
    <manufacturerName>Novoxel Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000008897</manufacturerSrn>
    <authorisedRepresentativeName>mdi Europa GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000006218</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12040218</emdnCode>
    <emdnDescription>ENDERMOLOGY TREATMENTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MSTX0002</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T00:33:18.762Z</lastUpdated>
  </row>
  <row>
    <udiDi>07290117520048</udiDi>
    <basicUdiDi>729011752TXLD0012VD</basicUdiDi>
    <tradeName>Tixel 2</tradeName>
    <deviceName>Tixel 2</deviceName>
    <manufacturerName>Novoxel Ltd.</manufacturerName>
    <manufacturerSrn>IL-MF-000008897</manufacturerSrn>
    <authorisedRepresentativeName>mdi Europa GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000006218</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12040218</emdnCode>
    <emdnDescription>ENDERMOLOGY TREATMENTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TXLD0012</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-03T00:33:18.073Z</lastUpdated>
  </row>
</eudamedExport>